Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank67
3Y CAGR+20.0%
5Y CAGR-43.3%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+20.0%/yr
Annual compound
5Y CAGR
-43.3%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.07 | +101.4% |
| 2024 | -4.66 | -302.3% |
| 2023 | 2.30 | +5941.1% |
| 2022 | 0.04 | -97.1% |
| 2021 | 1.33 | +18.0% |
| 2020 | 1.13 | +38906.7% |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |